Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer

For many years, the standard treatment for stage III colon cancer has been surgical resection followed by 5-fluorouracil in combination with folinic acid (5-FU/LV). Ongoing clinical trial evidence suggests that capecitabine and oxaliplatin (in combination with 5-FU/LV) may improve disease-free survi...

Descripción completa

Detalles Bibliográficos
Autores principales: Eggington, S, Tappenden, P, Pandor, A, Paisley, S, Saunders, M, Seymour, M, Sutcliffe, P, Chilcott, J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360578/
https://www.ncbi.nlm.nih.gov/pubmed/17031407
http://dx.doi.org/10.1038/sj.bjc.6603348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360578/
https://www.ncbi.nlm.nih.gov/pubmed/17031407
http://dx.doi.org/10.1038/sj.bjc.6603348

Ejemplares similares